NO923619L - Fremstilling av krystallinsk penem - Google Patents
Fremstilling av krystallinsk penemInfo
- Publication number
- NO923619L NO923619L NO92923619A NO923619A NO923619L NO 923619 L NO923619 L NO 923619L NO 92923619 A NO92923619 A NO 92923619A NO 923619 A NO923619 A NO 923619A NO 923619 L NO923619 L NO 923619L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- crystallization
- smaller
- carried out
- temperatures
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
- C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
- C07D477/20—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Fremgangsmåte for krystalllsering av (lR,5S,6S)-2- [ ( 6 ,7-dihydro-5E-pyrazolo[l ,2-a] [l ,2 , 4]triazolium-6- yl)]tio-6-[(R )-l-hydroksyetyl]-l-metyl-karbapenem-3- karboksylat (heretter forkortet som L-627), og er kjennetegnet ved at man opprettholder en vandig oppløsning med L-627 ved temperaturer l oppløsningen l området fra eutektisk temperatur til temperaturer lavere enn O'C. Fremgangsmåten medfører noen fordeler ved at tap av L- 627 som følge av krystallisasjon er mindre, antall trinn l fremstillingen av beholderformuleringene er mindre og opprettholdelse av disse trinnene under sterile og støvfrie betingelser kan enkelt bli . gjennomført, dlspensering av medikamentet kan bli gjennomført med kvantitativ nøyaktighet, og krystallene oppløses i et oppløsningsmlddel øyeblikkelig på anvendelsestldspunktet.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP24164891 | 1991-09-20 |
Publications (2)
Publication Number | Publication Date |
---|---|
NO923619D0 NO923619D0 (no) | 1992-09-17 |
NO923619L true NO923619L (no) | 1993-03-22 |
Family
ID=17077445
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO92923619A NO923619L (no) | 1991-09-20 | 1992-09-17 | Fremstilling av krystallinsk penem |
NO971332A NO971332D0 (no) | 1991-09-20 | 1997-03-21 | Fremstilling av krystallinsk penem |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO971332A NO971332D0 (no) | 1991-09-20 | 1997-03-21 | Fremstilling av krystallinsk penem |
Country Status (9)
Country | Link |
---|---|
US (2) | US5286856A (no) |
EP (1) | EP0533149A1 (no) |
JP (1) | JP2767171B2 (no) |
KR (1) | KR930006022A (no) |
FI (1) | FI924210A (no) |
IL (1) | IL103218A0 (no) |
NO (2) | NO923619L (no) |
TW (1) | TW264475B (no) |
ZA (1) | ZA927164B (no) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW264475B (no) * | 1991-09-20 | 1995-12-01 | Takeda Pharm Industry Co Ltd | |
DE69528166T2 (de) * | 1994-05-02 | 2003-04-30 | Shionogi & Co., Ltd. | Kristalline pyrrolidylthiocarbapenem derivate, lyophilisierste präparationen dieser kristalle und verfahren zu deren herstellung |
DE69930616T2 (de) * | 1998-03-02 | 2006-11-23 | Merck & Co., Inc. | Verfahren zur synthese von carbapenem-antibiotika |
DE10300620B4 (de) * | 2002-05-18 | 2017-04-13 | Carl Zeiss Meditec Ag | Trägervorrichtung für ein medizinisch-optisches Gerät |
KR101013535B1 (ko) * | 2004-10-21 | 2011-02-14 | 주식회사 만도 | 자동차의 파워 스티어링 장치용 실린더 튜브와 피드튜브의 조립 구조물 |
ZA200901949B (en) | 2006-09-25 | 2010-07-28 | Ptc Therapeutics Inc | Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid |
WO2009047604A1 (en) * | 2007-10-08 | 2009-04-16 | Orchid Chemicals & Pharmaceuticals Limited | Process for the preparation of carbapenem antibiotic |
DE102008043318A1 (de) | 2008-10-30 | 2010-05-12 | Mvg Metallverarbeitungsgesellschaft Mbh | Anhängekupplung |
WO2013132422A1 (en) * | 2012-03-05 | 2013-09-12 | Orchid Chemicals & Pharmaceuticals Ltd | An improved process for the preparation of carbapenem antibiotic |
TWI565707B (zh) | 2012-05-30 | 2017-01-11 | 明治製菓藥業股份有限公司 | 新穎β-內醯胺酶抑制劑及其製造方法 |
WO2014097221A1 (en) | 2012-12-21 | 2014-06-26 | Ranbaxy Laboratories Limited | Process for the purification of biapenem |
JP6453222B2 (ja) | 2013-09-24 | 2019-01-16 | Meiji Seikaファルマ株式会社 | ジアザビシクロオクタン誘導体の製造法とその中間体 |
AR097971A1 (es) | 2013-10-08 | 2016-04-20 | Meiji Seika Pharma Co Ltd | Formas cristalinas de derivado de diazabiciclooctano y proceso de producción de ellas |
BR112017010445B8 (pt) | 2014-12-05 | 2024-02-27 | Meiji Seika Pharma Co Ltd | Processo de produção de cristais de derivado de diazabiciclo-octano e preparação liofilizada estável |
CN114349772B (zh) * | 2020-10-13 | 2022-11-25 | 珠海联邦制药股份有限公司 | 一种比阿培南粗品的精制方法 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4029655A (en) * | 1975-04-11 | 1977-06-14 | Eli Lilly And Company | Method of preparing stable sterile crystalline cephalosporins for parenteral administration |
IL53427A0 (en) * | 1976-11-24 | 1978-01-31 | Lilly Co Eli | Method of preparing a rapidly dissolving powder of sterile crystalline cefozolin sodium for parenteral administration |
JPS6024080B2 (ja) * | 1977-06-01 | 1985-06-11 | 武田薬品工業株式会社 | 結晶の製造法 |
GB1589317A (en) * | 1977-11-24 | 1981-05-13 | Lilly Co Eli | Freeze drying cephalothin sodium |
JPS56120615A (en) * | 1980-02-27 | 1981-09-22 | Nippon Chemiphar Co Ltd | Preparation of lyophilized powder of cephalothin |
US4713451A (en) * | 1984-04-09 | 1987-12-15 | Merck & Co., Inc. | Crystalline dimethyliminothienamycin |
IE60588B1 (en) * | 1986-07-30 | 1994-07-27 | Sumitomo Pharma | Carbapenem compound in crystalline form, and its production and use |
US4866171A (en) * | 1987-04-11 | 1989-09-12 | Lederle (Japan), Ltd. | (1R,5S,6S)-2-[(6,7-dihydro-5H-pyrazolo[1,2-a][1,2,4]triazolium-6-yl)]thio-6-[R-1-hydroxyethyl]-1-methyl-carbapenum-3-carboxylate |
JPS6425779A (en) * | 1987-04-11 | 1989-01-27 | Lederle Japan Ltd | (1r,5s,6s)-2-substituted-thio-6-((r)-1-hydroxyethyl)-1-methyl -carbapenem-3-carboxylic acid derivative |
DK168047B1 (da) * | 1987-12-07 | 1994-01-24 | Lederle Japan Ltd | (1r,5s,6s)-2-substitueret thio-6-oe(r)-1-hydroxyethylaa-1-methyl-carbapenem-3-carboxylsyrederivater, fremgangsmaade til remstilling deraf, midler og praeparater indeholdende den krystallinske forbindelse samt dens anvendelse. |
US5082661A (en) * | 1990-09-26 | 1992-01-21 | Elizabeth Arden Co., Division Of Conopco, Inc. | Odorless cosmetic compositions in gelatin capsules |
GB9021061D0 (en) * | 1990-09-27 | 1990-11-07 | Unilever Plc | Encapsulating method and products containing encapsulated material |
TW264475B (no) * | 1991-09-20 | 1995-12-01 | Takeda Pharm Industry Co Ltd | |
NZ261497A (en) * | 1993-01-29 | 1997-06-24 | Agouron Pharma | 2-[4-[2-(2-amino-4-oxo-3h-pyrido[5,4-b]n-hetring)-ring containing hydrocarbyl chain]-amido]-pentanedioic acid |
-
1992
- 1992-09-16 TW TW081107287A patent/TW264475B/zh active
- 1992-09-17 EP EP92115869A patent/EP0533149A1/en not_active Withdrawn
- 1992-09-17 NO NO92923619A patent/NO923619L/no unknown
- 1992-09-18 IL IL103218A patent/IL103218A0/xx unknown
- 1992-09-18 KR KR1019920017057A patent/KR930006022A/ko not_active Application Discontinuation
- 1992-09-18 JP JP4249767A patent/JP2767171B2/ja not_active Expired - Lifetime
- 1992-09-18 FI FI924210A patent/FI924210A/fi not_active Application Discontinuation
- 1992-09-18 ZA ZA927164A patent/ZA927164B/xx unknown
- 1992-09-18 US US07/946,614 patent/US5286856A/en not_active Expired - Fee Related
-
1993
- 1993-11-30 US US08/159,252 patent/US5424069A/en not_active Expired - Fee Related
-
1997
- 1997-03-21 NO NO971332A patent/NO971332D0/no unknown
Also Published As
Publication number | Publication date |
---|---|
US5424069A (en) | 1995-06-13 |
NO971332D0 (no) | 1997-03-21 |
FI924210A0 (fi) | 1992-09-18 |
NO923619D0 (no) | 1992-09-17 |
AU645442B2 (en) | 1994-01-13 |
EP0533149A1 (en) | 1993-03-24 |
FI924210A (fi) | 1993-03-21 |
US5286856A (en) | 1994-02-15 |
NO971332L (no) | 1993-03-22 |
AU2459792A (en) | 1993-03-25 |
JPH05271241A (ja) | 1993-10-19 |
JP2767171B2 (ja) | 1998-06-18 |
ZA927164B (en) | 1994-03-18 |
IL103218A0 (en) | 1993-02-21 |
TW264475B (no) | 1995-12-01 |
KR930006022A (ko) | 1993-04-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO923619L (no) | Fremstilling av krystallinsk penem | |
AU7035094A (en) | New 11-benzaldoxime-estradiene-derivatives, methods for their production and pharmaceuticals containing these substances | |
ES8609303A1 (es) | Un procedimiento para la preparacion de un derivado de acido6-fluor-1,4-dihidro-4-oxo-7-piperazinilquinolin sustituido-3-carboxilico | |
AU2001261079B2 (en) | Process for formulation of antibiotic compounds | |
AU7035194A (en) | 11-benzaldoxime-17beta-methoxy-17alpha- methoxymethylestradiene-derivatives, methods for their production and pharmaceuticals containing these substances | |
AU2001261079A1 (en) | Process for formulation of antibiotic compounds | |
ATE698T1 (de) | Analgetische 6-acylaminot etrahydro-1,3,5-triazin-2,4-dion-derivate, sie enthaltende pharmazeutische zusammensetzungen und verfahren zu ihrer herstellung. | |
FI103576B1 (fi) | Menetelmä lääkeaineena käyttökelpoisen kiteisen karbapeneemijohdannaisen valmistamiseksi | |
GB939901A (en) | Improvements in or relating to amino pyrazoles | |
NO176102C (no) | Fremgangsmåte ved fremstilling av carbapenemderivater og deres utgangsmaterialer | |
CN1004001B (zh) | 新晶型苯并噻嗪二氧化物盐的制备方法 | |
US20020002160A1 (en) | Process for formulation of antibiotic compounds | |
GR890100493A (el) | Μεθοδος για την παρασκευη κρυσταλλικου (5r,6s)-2-καρβομουλομεθυλ-6-(1r)-υδροξυεθυλ-2-πενεμ-καρβοξυλικου οξεος και της φαρμακευτικης του διαμορφωσης. | |
JPS61172878A (ja) | カルバペネム誘導体の安定な凍結乾燥製剤の製法 | |
DK411488A (da) | (1r,5s,6s)-2-substitueret thio-6-oe(r)-1-hydroxyethylaa-1-methyl-carbapenem-3-carboxylsyrederivater, fremgangsmaader til deres fremstilling samt deres anvendelse | |
EP0363826A3 (en) | Crystalline dihydrochloride of cephalosporin derivative and a method for preparation thereof | |
ES8600767A1 (es) | Un procedimiento para la preparacion de derivados de 7-oxo-1-azabiciclo (3.2.0) hepteno | |
IE32961B1 (en) | New dialkylaminoalkyl ethers of 2-alkoxy-3,5-dihalobenzene and process for the preparation thereof | |
JPS6479138A (en) | 1-biphenylylethanol derivative and production thereof | |
NO986185L (no) | 7-brom- og 7,7-dibrom-cefam- og -cefem-derivater | |
SU1170792A1 (ru) | Способ получения цезия | |
JPS57131778A (en) | Novel 7-oxabicyclo(4.1.0)heptane-3-carboxylic acid derivative | |
JPS5246066A (en) | Preparation of optically active 5-oxo-2-pyrrolipinyl acetic acid salts |